Diagnostic and prognostic value of soluble CD14 subtype (Presepsin) for sepsis and community-acquired pneumonia in ICU patients

Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin

(2016) Alfredo Enguix-Armada et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Presepsin (sCD14-ST), an innate immune response marker in sepsis

(2015) Camille Chenevier-Gobeaux et al.   CLINICA CHIMICA ACTA

Utility of presepsin (sCD14-ST) as a diagnostic and prognostic marker of sepsis in the emergency department

(2015) Ricardo Carpio et al.   CLINICA CHIMICA ACTA

The accuracy of presepsin for the diagnosis of sepsis from SIRS: a systematic review and meta-analysis

(2015) Zhongjun Zheng et al.   Annals of Intensive Care

Clinical Impact of Kidney Function on Presepsin Levels

(2015) Takanobu Nagata et al.   PLoS One

Accuracy of Presepsin in Sepsis Diagnosis: A Systematic Review and Meta-Analysis

(2015) Jiayuan Wu et al.   PLoS One

Diagnostic accuracy of presepsin (soluble CD14 subtype) for prediction of bacteremia in patients with systemic inflammatory response syndrome in the Emergency Department

(2014) Luis García de Guadiana Romualdo et al.   CLINICAL BIOCHEMISTRY

Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial

(2014) Serge Masson et al.   INTENSIVE CARE MEDICINE

Role of Presepsin (sCD14-ST) and the CURB65 scoring system in predicting severity and outcome of community-acquired pneumonia in an emergency department

(2014) Bo Liu et al.   RESPIRATORY MEDICINE

Blood biomarkers for personalized treatment and patient management decisions in community-acquired pneumonia

(2013) Philipp Schuetz et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Clinical Outcomes Associated With Procalcitonin Algorithms to Guide Antibiotic Therapy in Respiratory Tract Infections

(2013) Philipp Schuetz et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Serial quantification of procalcitonin (PCT) predicts clinical outcome and prognosis in patients with community-acquired pneumonia (CAP)

(2013) Masaki Tamura et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis

(2013) Christina Wacker et al.   LANCET INFECTIOUS DISEASES

Severe Sepsis and Septic Shock

(2013) Derek C. Angus et al.   NEW ENGLAND JOURNAL OF MEDICINE

Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study

(2012) Shigeatsu Endo et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Diagnostic and Prognostic Value of Procalcitonin in Community-Acquired Pneumonia

(2011) Masafumi Horie et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Development of a point-of-care assay system for measurement of presepsin (sCD14-ST)

(2011) Yoshikazu Okamura et al.   CLINICA CHIMICA ACTA

Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients

(2011) Kamon Shirakawa et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome

(2011) Tatsuyori Shozushima et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Procalcitonin Levels Predict Bacteremia in Patients With Community-Acquired Pneumonia

(2010) Fabian Müller et al.   CHEST

Procalcitonin and C-Reactive Protein in Hospitalized Adult Patients With Community-Acquired Pneumonia or Exacerbation of Asthma or COPD

(2010) Mona Bafadhel et al.   CHEST

Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic Shock

(2009) Anand Kumar et al.   CHEST